跳至主要内容
临床试验/NCT07201194
NCT07201194招募中不适用

HOL-AKU: Holistic Acupuncture for Patients With Chemotherapy Induced Nausea

Vejle Hospital2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年11月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
90
试验地点
2
主要终点
Patient reported nausea assessed on the EORTC-15-PAL Scale

研究概览

简要总结

The study explores whether acupuncture as a supplement to conventional antiemetic medicine is superior in reducing the level of chemotherapy induced nausea compared to conventional anitemetic medicine alone.

A total of 90 patients experiencing chemotherapy induced nausea will be allocated 1:1 to either acupuncture and antiemetic medicine or antiemetic medicine alone.

The level of nausea and other cancer related symptoms will be assessed at baseline and 8 and 22 days after enrollment

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 18 years of age
  • Undergoing chemotherapy and experiencing nausea despite adherence to the prescribed antiemetic regimen
  • Understands and speaks Danish
  • Written and orally informed consent
  • Planned for treatment every 14 days
  • At least two chemotherapy cycles planned at the time of inclusion

排除标准

  • Brain metastases
  • Performance status >2

研究组 & 干预措施

Holistic acupuncture and acupressure

Experimental

Holistic acupuncture and acupressure as a supplement to standard care

干预措施: Holistic acupuncture and acupressure (Other)

Standard care

Active Comparator

干预措施: Standard medical treatment (Other)

结局指标

主要结局

Patient reported nausea assessed on the EORTC-15-PAL Scale

时间窗: 8 days after enrollment

次要结局

  • Patient reported symptom intensity according to the EORTC-15 PAL Scale(8 and 22 days after enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验